抗磷脂综合征相关心血管疾病的表现及新进展

Research Update on the Phenotype of Cardiovascular Diseases Associated With Antiphospholipid Syndrome

抗磷脂综合征(APS)是以反复发生血栓事件和妊娠并发症以及抗磷脂抗体持续阳性为特点的一种系统性自身免疫性疾病。APS可以影响包括心血管系统在内的多个器官和系统,APS相关心血管疾病会给患者生命造成严重威胁。在2023年更新的美国风湿病学会(ACR)联合欧洲抗风湿病联盟(EULAR)APS分类标准中,将瓣膜病变纳入了APS的临床标准,这也提示应该重视APS合并的心血管疾病。本文将对APS合并的常见心血管疾病的表现及机制进行综述。

Antiphospholipid syndrome is a systemic autoimmune disease characterized by recurrent thrombotic events,pregnancy complications and persistent positive antiphospholipid antibodies.As a systemic disease,antiphospholipid syndrome can affect multiple organs and systems,including the cardiovascular system.Antiphospholipid syndrome-related cardiovascular diseases can cause serious threats to patients'lives.In the updated ACR/EULRA classification criteria for antiphospholipid syndrome issued in 2023,valvular disease has been included in the clinical criteria of antiphospholipid syndrome,which highlights the importance of considering cardiovascular diseases associated with antiphospholipid syndrome.This article reviews the research progress on the phenotype and mechanisms of cardiovascular diseases associated with antiphospholipid syndrome.